Amgen announced that the European Commission has granted conditional marketing authorization for LUMYKRAS® (sotorasib), a first-in-class KRASG12C inhibitor, for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and who have progressed after at least one prior line of systemic therapy. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Ready for career opportunity? Explore what's possible in our SAS Academy for Clinical Programming
Become a SAS® Certified Clinical Trials Programmer
The pharmaceutical industry is bursting at the seams with data and looking for talented, skillful programmers. SAS® is the de facto standard platform used for clinical trials data analysis and reporting for new product submissions to regulatory authorities. SAS® is widely recognized as the gold standard for determining safety and efficacy for clinical trials. SAS® is also the primary mechanism for preparing analysis-ready data for traditional clinical research safety and efficacy analysis activities.
Are you intrigued?
Our new training program combines coursework and hands-on learning for you or your team to gain valuable clinical research theory and data analysis skills. What's it all about? The academy offers three tracks based on career aspirations:
SAS® Clinical Programming Fundamentals
SAS® Applied Clinical Data Analysis and Reporting
SAS® Certified Clinical Trials Programmer
SAS® certification credentials are globally recognized. Don't miss out on this opportunity!
Contact Us
To contact SAS India via postal mail: SAS, Maker Maxity Bandra-Kurla Complex, 3rd Floor, 4th North Avenue & 5th North Avenue, Bandra (East), Mumbai - 400051 Maharashtra Attention: Legal Division/Privacy Manager.
SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies.
Copyright © SAS Institute Inc. All rights reserved.










